Register entry
- Registered sites
- 0
- Active NDC listings
- 4
- Live patents
- 0
- Countries
- 0
Catalogue
Drug listings by form and route
44 active NDC listings: 4 human prescription drug. By marketing category: BLA 4.
| Dosage form | NDCs |
|---|---|
| injection, solution | 4 |
| Route | NDCs |
|---|---|
| intravitreal | 2 |
| subcutaneous | 2 |
| Labeller name on the listing | NDCs |
|---|---|
| coherus biosciences inc | 4 |
Catalogue
Marketed products
4| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| CIMERLI | ranibizumab-eqrn | injection, solution, intravitreal | 70114-440BLA |
| CIMERLI | ranibizumab-eqrn | injection, solution, intravitreal | 70114-441BLA |
| YUSIMRY | adalimumab-aqvh | injection, solution, subcutaneous | 70114-210BLA |
| YUSIMRY | adalimumab-aqvh | injection, solution, subcutaneous | 70114-220BLA |
Compare
Other companies listing adalimumab-aqvh
- Meitheal Pharmaceuticals, Inc.0 sites · 171 NDC
Enquiry
Common questions
- Is Coherus BioSciences Inc FDA approved?
- Coherus BioSciences Inc holds no registered establishment of its own; 4 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does Coherus BioSciences Inc make?
- 4 products are listed under Coherus BioSciences Inc in the openFDA NDC Directory, most often as injection, solution. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.